Tsolmon Munkhchuluun

Dr. Tsolmon Munkhchuluun

researcher at National Center for Public Health
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Altantuya TsevgeeAltantuya Tsevgee
Altantuya Tsevgee
Khishigjargal BatjargalKhishigjargal Batjargal
Khishigjargal Batjargal
Tsolmon MunkhchuluunTsolmon Munkhchuluun
Tsolmon Munkhchuluun
NKNaranchimeg Khurelbaatar
Naranchimeg Khurelbaatar
GNGerelmaa Nansal
Gerelmaa Nansal
EGErdenetuya Ganbaatar
Erdenetuya Ganbaatar
Congenital hypothyroidism (CH) is among the most common conditions leading to intellectual disability, which can be prevented by early detection through newborn screening (NBS). In Mongolia, a regional screening program for CH was launched in 2000, which was supported by the International Atomic Energy Agency (IAEA) for the Asia Pacific Region. In our present study, a total of 23,002 newborns from nine districts in Ulaanbaatar were screened between 2012 and 2020, by the measurement of the thyroid-stimulating hormone (TSH) from dried blood spots, sampled 24 to 72 h after birth. The level of TSH was measured by the DELFIA assay. The overall CH prevalence confirmed at birth was 1/2091. The female-to-male ratio for CH cases was 1.8:1. The majority of patients were asymptomatic (72.7% of CH cases); umbilical hernia and cold or mottled skin were reported symptoms in patients with CH (27.3%). Thyroid dysgenesis (hypoplasia and agenesis) was the most common etiology, with a total of nine cases (81.8%) out of the eleven patients. The lapse between the birth date and the initiation of L-thyroxine treatment in CH-positive children was lower than 15 days in 63.64% of cases or 15 to 30 days in 36.36% of children. Further research is required to expand the screening coverage for CH in Mongolia.